Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

34.49
Delayed Data
As of 4:00pm ET
 +0.58 / +1.71%
Today’s Change
8.00
Today|||52-Week Range
63.73
-10.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.9B

Company Description

Sarepta Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the discovery and development of unique RNA-based therapeutics for the treatment of rare and infectious diseases. The company is primarily focused on rapidly advancing the development of its potentially disease modifying duchenne muscular dystrophy drug candidates. Sarepta Therapeutics was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Contact Information

Sarepta Therapeutics, Inc.
215 First Street
Cambridge Massachusetts 02142
P:(857) 242-4000
Investor Relations:
(617) 274-4052

Employees

Shareholders

Individual stakeholders6.95%
Other institutional52.62%
Mutual fund holders27.50%

Top Executives

Edward M. KayePresident, Chief Executive & Medical Officer
Gavin T. MalenfantHead-Operations & Vice President
Sandesh MahatmeChief Financial Officer & Senior Vice President
TY HowtonSecretary, Senior Vice President & General Counsel
Alexander CumboSenior Vice President